AN2 THERAPEUTICS INCANTX
ASignal's systematic analysis rates ANTX as Bearish.
Reflects the latest available analysis · analyzed Oct 15, 2026
The case on ANTX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- High cash position ($78.39M) with zero debt
- Current ratio of 14.32x indicates strong liquidity
- RSI at 28.38 suggests potential oversold condition
- Negative return on equity (-50.12%) and return on assets (-30.80%)
- Negative operating cash flow ($-30.68M) and free cash flow ($-18.02M)
- All margin metrics at 0.00%, indicating no profitability
- Forward P/E of -4.46x reflects negative earnings expectations
- Low news coverage with only one source (Yahoo)
- No Reddit mentions, indicating lack of retail interest
See the full verdict on ANTX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ANTX
Most investors never get a second opinion, let alone several. ASignal runs ANTX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.